ArticleBMC cancer2022

Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).

Taro Shibuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.